A 7 page discussion of the causes and effects of osteoporosis. This paper reveals a number of interventional methodologies which are useful in combating the condition. The importance of hormones in this condition is emphasized and interventional approaches such as estrogen replacement therapy, vitamin regimes including vitamins D and calcium, as well as the importance of other hormone replacement therapies such as that which is available for growth hormone, cakitonin, bisphosphonates and those known as Selective Estrogen Receptor Modulators (SERMS). Bibliography lists 10 sources.
Name of Research Paper File: AM2_PPosteo2.rtf
Unformatted Sample Text from the Research Paper:
2001). By 2015 the total number of individuals suffering from the condition in the U.S. is projected as high as forty-one million (McClung, 2001). An astounding eighty percent
of this number is women (McClung, 2001). This condition, also know as "Brittle Bone Disease", in fact, affects primarily postmenopausal women (McGee PG). The majority of bone loss
in these women occurs in the first five to ten years after menopause (Minkin, 2001). Osteoporosis can be classified as either
primary or secondary. While secondary osteoporosis is related to certain diseases and treatments, primary osteoporosis is related to estrogen deficiency (Burke, 2001). Estrogen replacement therapy (ERT) is, in
fact, one of the most frequently recommended interventions for osteoporosis. McClung (2001, PG) notes:
"Studies have shown that ERT (taken orally or delivered through a patch) prevents bone loss and reduces fracture risk in postmenopausal women. Estrogen replacement therapy is effective early in menopause
and in older postmenopausal women with established osteoporosis. If ERT is discontinued, though, bone loss will quickly resume".
While it is important to address estrogen levels in osteoporosis, there are other considerations as well. Some women cant take estrogen for fear of increased risks
of breast cancer or a multitude of other reasons. In this case the drugs known as bisphosphonates and those known as Selective Estrogen Receptor Modulators (SERMS), present an
alternative (McClung, 2001). Although these drugs arent hormones they have been proven to effectively reduce bone loss (McClung, 2001). Cakitonin is a calcium regulating hormone which is also